Medications requiring prior authorization across health insurance plans

Author:

Jones Laney K1,Ladd Ilene G1,Gionfriddo Michael R2,Gregor Christina2,Evans Michael A3,Graham Jove2

Affiliation:

1. Genomic Medicine Institute, Geisinger, Danville, PA

2. Center for Pharmacy Innovation and Outcomes, Geisinger, Danville, PA

3. Enterprise Pharmacy, Geisinger, Danville, PA

Abstract

AbstractObjectiveTo determine the amount of variation in numbers and types of medications requiring prior authorization (PA) by insurance plan and type.MethodsMost health insurance companies require PA for medications to ensure safe and effective use and contain costs. We generated 4 lists of medications that required PA during 2017 for commercial, marketplace, Medicaid, and Medicare plans. We aggregated medications according to the generic medication name equivalent using codes and medication names. We compared these medications to assess how many of the medications required PA by 1, 2, 3, or all 4 of the insurance plans. We counted all prescription orders written for a patient age 18 years or older with health plan insurance during 2017 for any of the medications that appeared on the health plan’s PA lists by querying the electronic health record.ResultsPA was required for 600 unique medications in 2017 across the 4 plans. Of 691,457 prescription orders written for 114,159 members, 31,631 (5%) were written for 1 of the 600 medications that required PA by at least 1 insurance plan. There were 12,540 medication orders (written for 6,642 members) that potentially required PA. The marketplace plan required PA for the greatest number of medications (440), followed by the Medicare (272), commercial (271), and Medicaid (72) plans. The most commonly prescribed classes of medications for which PA was required by at least 1 plan were antihyperlipidemics (22% of orders potentially requiring PA), narcotic analgesics (13%), hypnotics (12%), antidiabetic medications (9%), and antidepressants (9%). For only 25% of medications (151 of 600) was PA required by at least 3 plans, and for only 5% (32 of 600) was PA required by all 4 insurance types.ConclusionMedications requiring PA can differ within a single health insurance company, but this variation may be unavoidable due to external factors.

Funder

Pennsylvania Department of Health

Publisher

Oxford University Press (OUP)

Subject

Health Policy,Pharmacology

Reference16 articles.

1. Evaluating the operational performance and financial effects of a drug prior authorization program;Phillips;J Manag Care Pharm,1997

2. Prior authorization and utilization management concepts in managed care pharmacy;Academy of Managed Care Pharmacy Professional Practice Committee.;J Manag Care Spec Pharm,2019

3. Coverage of atypical antipsychotics among medicare drug plans in the state of washington for fiscal year 2007;Wang;Prim Care Companion J Clin Psychiatry.,2008

4. Prior authorization for biologic disease-modifying antirheumatic drugs: a description of US medicaid programs;Fischer;Arthritis Rheum.,2008

5. Identifying widely covered drugs and drug coverage variation among medicare part D formularies;Tseng;JAMA.,2007

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3